Amgen (AMGN) Tops Q1 EPS by 38c; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
Go back to Amgen (AMGN) Tops Q1 EPS by 38c; Boosts FY15 Outlook
April 22, 2015 11:41 AM EDT
In a note earlier, Jefferies analyst Eun K. Yang reiterated a Buy rating and boosted his price target on Amgen (NASDAQ: AMGN) to $195.00 (from $182.00) following Q1 results.
Yang commented, "Reported ~18% higher EPS (vs. cons) on ~3% higher product sales & lower OpEx; upped FY15 EPS guidance... More
April 22, 2015 7:49 AM EDT
Leerink Partners analyst Howard Liang reiterated an Outperform rating and boosted estimates and his price target on Amgen (NASDAQ: AMGN) to $187.00 (from $177.00) following strong results.
Liang commented, "AMGN reported a strong first quarter last night, with a broad range of products contributing to a ~$117M sales beat vs. consensus and approximately twice this number in lower-than-expected operating expenses, leading to... More
April 21, 2015 2:09 PM EDT
Amgen (NASDAQ: AMGN) is up 1% into earnings after the close of trading today. Analysts on average are looking for EPS of $2.10 on revenues of $4.91 billion, representing year-over-year growth of 12% and 9%, respectively. On average over the past four quarters, the company has beaten the EPS consensus by 6%. The... More
